Further investigation into the pathophysiological pathways linking inflammation and erythropoietin resistance—particularly those related to the malnutrition–inflammation complex and PEW syndrome—may provide new therapeutic targets to optimize anemia control in this vulnerable population. The gene discussed is EPO; the disease is anemia.